Assessment of the Role of Selected SMAD3 and SMAD4 Genes Polymorphisms in the Development of Colorectal Cancer: Preliminary Research

References

• Kamocki ZK, Wodynska NA, Zurawska JL, Zareba KP. Significance of selected morphological and histopathological parameters of colon tumors as prognostic factors of cancer spread. Turk J Gastroenterol. 2017;28(4):248–253. doi:10.5152/tjg.2017.16734
   Web of Science ®Google Scholar
• Jacobs D, Zhu R, Luo J, et al. Defining early-onset colon and rectal cancers. Front Oncol. 2018;8:504. doi:10.3389/fonc.2018.00504
   Web of Science ®Google Scholar
• Sameer AS. Colorectal cancer: molecular mutations and polymorphisms. Front Oncol. 2013;3:114. doi:10.3389/fonc.2013.00114
   PubMedGoogle Scholar
• Druliner BR, Ruan X, Sicotte H, et al. Early genetic aberrations in patients with sporadic colorectal cancer. Mol Carcinog. 2018;57(1):114–124. doi:10.1002/mc.22738
   Web of Science ®Google Scholar
• Wideł MS, Wideł M. Mechanizmy przerzutowania i molekularne markery progresji nowotworów złośliwych. I. Rak jelita grubego. Postepy Hig Med Dosw. 2006;60:453–470.
   Google Scholar
• Tian M, Schiemann WP. The TGF-beta paradox in human cancer: an update. Future Oncol. 2009;5:259–271. doi:10.2217/14796694.5.2.259
   PubMed Web of Science ®Google Scholar
• Akhurst RJ, Hata A. Targeting the TGFbeta signalling pathway in disease. Nat Rev Drug Discov. 2012;11:790–811.
   PubMed Web of Science ®Google Scholar
• Attisano L, Wrana JL. Signal transduction by the TGF-beta superfamily. Science. 2002;296:1646–1647. doi:10.1126/science.1071809
   PubMed Web of Science ®Google Scholar
• Slattery ML, Herrick JS, Lundgreen A, Wolff RK. Genetic variation in the TGF-β-signaling pathway and colon and rectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2011;20(1):57–69. doi:10.1158/1055-9965.EPI-10-0843
   Web of Science ®Google Scholar
• Li Q, Wu H, Chen B, et al. SNPs in the TGF-βsignaling pathway are associated with increased risk of brain metastasis in patients with non-small-cell lung cancer. PLoS One. 2012;7(12):e51713. doi:10.1371/journal.pone.0051713
   Web of Science ®Google Scholar
• Schmierer B, Hill CS. TGFβ–SMAD signal transduction: molecular specificity and functional flexibility. Nat Rev Mol Cell Biol. 2007;8(12):970. doi:10.1038/nrm2297
   PubMed Web of Science ®Google Scholar
• Slattery ML, Lundgreen A, Herrick JS, et al. Associations between genetic variation in RUNX1, RUNX2, RUNX3, MAPK1 and eIF4E and risk of colon and rectal cancer: additional support for a TGF-β-signaling pathway. Carcinogenesis. 2011;32(3):318–326. doi:10.1093/carcin/bgq245
   PubMed Web of Science ®Google Scholar
• Woodford-Richens KL, Rowan AJ, Gorman P, et al. SMAD4 mutations in colorectal cancer probably occur before chromosomal instability, but after divergence of the microsatellite instability pathway. Proc Natl Acad Sci USA. 2001;98(17):9719–9723. doi:10.1073/pnas.171321498
   Web of Science ®Google Scholar
• Fleming NI, Jorissen RN, Mouradov D, et al. SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res. 2013;73(2):725–735. doi:10.1158/0008-5472.CAN-12-2706
   PubMed Web of Science ®Google Scholar
• Du X, Pan Z, Li Q, Liu H, Li Q. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis. Cell Death Dis. 2018;9(2):151. doi:10.1038/s41419-017-0205-2
   PubMed Web of Science ®Google Scholar
• Salovaara R, Roth S, Loukola A, et al. Frequent loss of SMAD4/DPC4 protein in colorectal cancers. Gut. 2002;51(1):56–59. doi:10.1136/gut.51.1.56
   PubMed Web of Science ®Google Scholar
• Sarshekeh AM, Advani S, Overman MJ, et al. Association of SMAD4 mutation with patient demographics, tumor characteristics, and clinical outcomes in colorectal cancer. PLoS One. 2017;12(3):e0173345. doi:10.1371/journal.pone.0173345
   Web of Science ®Google Scholar
• Mithani SK, Balch GC, Shiou S-R, Whitehead RH, Datta PK, Beauchamp RD. Smad3 has a critical role in TGF-β-mediated growth inhibition and apoptosis in colonic epithelial cells. J Surg Res. 2004;117(2):296–305. doi:10.1016/S0022-4804(03)00335-4
   Web of Science ®Google Scholar
• van de Laar IM, van der Linde D, Oei EH, et al. Phenotypic spectrum of the SMAD3-related aneurysms-osteoarthritis syndrome. J Med Genet. 2012;49:47–57. doi:10.1136/jmedgenet-2011-100382
   Web of Science ®Google Scholar
• Zhang L, Zhang H, Wang W, Zhao Y. Association between SMAD3 gene rs12901499 polymorphism and knee osteoarthritis in a Chinese population. J Clin Lab Anal. 2018;32:e22383. doi:10.1002/jcla.22383
   PubMed Web of Science ®Google Scholar
• Wu DM, Zhu HX, Zhao QH, et al. Genetic variations in the SMAD4 gene and gastric cancer susceptibility. World J Gastroenterol. 2010;16(44):5635–5641. doi:10.3748/wjg.v16.i44.5635
   PubMed Web of Science ®Google Scholar
• Paradowska-Gorycka A, Romanowska-Prochnicka K, Haladyj E, Manczak M, Maslinski S, Olesinska M. Association of the Smad3 and NFATc2 gene polymorphisms and their serum levels with susceptibility to rheumatoid arthritis in Polish cohorts. Clin Exp Immunol. 2015;179(3):444–453. doi:10.1111/cei.12482
   Web of Science ®Google Scholar
• Maitra A, Molberg K, Albores-Saavedra J, et al. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease. Am J Pathol. 2000;157(4):1105–1111. doi:10.1016/S0002-9440(10)64625-1
   Web of Science ®Google Scholar
• Xie W, Rimm DL, Lin Y, et al. Loss of smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis. Cancer J. 2003;9(4):302–312. doi:10.1097/00130404-200307000-00013
   Web of Science ®Google Scholar
• Alazzouzi H, Alhopuro P, Salovaara R, et al. SMAD4 as a prognostic marker in colorectal cancer. Clin Cancer Res. 2005;11(7):2606–2611.
   Web of Science ®Google Scholar
• Miyaki M, Iijima T, Konishi M, et al. Higher frequency of Smad4 gene mutation in human colorectal cancer with distant metastasis. Oncogene. 1999;18(20):3098–3103. doi:10.1038/sj.onc.1202642
   PubMed Web of Science ®Google Scholar
• Samani NJ, Erdmann J, Hall AS, et al. Genome wide association analysis of coronary artery disease. N Engl J Med. 2007;357:443–453. doi:10.1056/NEJMoa072366
   PubMed Web of Science ®Google Scholar
• Doaei S, Hajiesmaeil M, Aminifard A, et al. Effects of gene polymorphisms of metabolic enzymes on the association between red and processed meat consumption and the development of colon cancer; a literature review. J Nutr Sci. 2018;7(26):1–7. doi:10.1017/jns.2018.17
   Web of Science ®Google Scholar